Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04855032 · ClinicalTrials.gov registry record · NA

Post-stroke Perturbation Training

A NA study of Stroke, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
86
Enrollment target
1
Study location

NCT04855032 is a NA study of Stroke that has completed, run by Medical University of South Carolina. The registered enrollment target is 86 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04855032, a NA study of Stroke, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target
1
Study location

Study Summary

Following a stroke, many individuals have a high risk of falls, which can negatively influence quality of life. Unfortunately, current treatments have not effectively addressed this problem. This study investigates whether two methods of delivering mechanical perturbations during walking have the potential to improve post-stroke walking balance and reduce real-world fall incidence.

Conditions Studied

Interventions

  • BEHAVIORAL Reactive Perturbations
  • BEHAVIORAL Proactive Perturbations

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2021-10-06
Est. Completion 2025-12-05
Phase NA

What the Registry Record Tells You About NCT04855032

The ClinicalTrials.gov registry entry for NCT04855032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Reactive Perturbations is the first listed.

NCT04855032 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT04855032 about?

NCT04855032 is a clinical study titled "Post-stroke Perturbation Training". Following a stroke, many individuals have a high risk of falls, which can negatively influence quality of life. Unfortunately, current treatments have not effectively addressed this problem. This study investigates whether two methods of delivering mechanical perturbations during walking have the po...

What is the current status of trial NCT04855032?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2021-10-06. Estimated completion is 2025-12-05.

What conditions does trial NCT04855032 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04855032?

The interventions under investigation include: Reactive Perturbations (BEHAVIORAL), Proactive Perturbations (BEHAVIORAL).

Who is sponsoring clinical trial NCT04855032?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04855032 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.